Mvabea

Modified Vaccinia Ankara - Bavarian Nordic Virus Encoding The Ebola Virus Zaire Mayinga Strain Glyco, the active ingredient in Mvabea, is a vaccine presented as a vaccine for intramuscular use. It is intended to prevent Ebola virus disease caused by the Zaire strain in individuals at risk of exposure. GNH USA supplies Mvabea as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mvabea is a viral vaccine used to protect against Ebola virus disease (Zaire strain). - Ebola virus disease (Zaire strain): provides protective immunity to prevent infection. - High‑risk healthcare workers: reduces risk of Ebola acquisition during outbreak response. - Contacts of confirmed cases: helps prevent secondary transmission in exposed individuals.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Redness or swelling: localized erythema or edema. - Low‑grade fever: transient temperature rise. - Headache: mild headache lasting a few hours. - Fatigue: temporary tiredness. - Muscle aches: mild myalgia.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis requiring immediate medical attention. - Neurological events: rare cases of Guillain‑Barré‑like syndrome. - Thrombocytopenia: low platelet count observed in isolated reports. - Autoimmune manifestations: very rare autoimmune phenomena. - Severe injection site reactions: necrosis or extensive ulceration.

Before administration, consider the following precautions: - Contraindication: known hypersensitivity to any component of the vaccine. - Immunocompromised patients: assess risk‑benefit as immune response may be reduced. - Pregnancy: use only if benefits outweigh potential risks; data are limited. - Breastfeeding: weigh potential benefits against unknown infant exposure. - Age restrictions: not recommended for individuals outside the approved age range. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Major Interactions (Avoid): - Live viral vaccines: concurrent administration may interfere with immune response. - Immunosuppressive therapy: may diminish vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antipyretics: may mask fever, monitor for underlying reactions. - Corticosteroids: could reduce immunogenicity, consider timing. - Anticoagulants: monitor injection site for prolonged bleeding.